|
FAM169A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.9232000021735E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3825999999616E-06 |
| Normal-vs-Stage2 |
1.372370E-02 |
| Normal-vs-Stage3 |
1.91189997167385E-09 |
| Normal-vs-Stage4 |
2.41939801526314E-12 |
| Stage1-vs-Stage2 |
4.339400E-01 |
| Stage1-vs-Stage3 |
9.854100E-02 |
| Stage1-vs-Stage4 |
4.02150000000656E-05 |
| Stage2-vs-Stage3 |
7.870200E-02 |
| Stage2-vs-Stage4 |
1.895270E-03 |
| Stage3-vs-Stage4 |
1.448180E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93790000047045E-07 |
| Normal-vs-AfricanAmerican |
2.622500E-03 |
| Normal-vs-Asian |
3.87590004535809E-09 |
| Caucasian-vs-AfricanAmerican |
7.938400E-01 |
| Caucasian-vs-Asian |
1.268430E-01 |
| AfricanAmerican-vs-Asian |
2.812200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.58139953857039E-10 |
| Normal-vs-Female |
5.86329999996416E-07 |
| Male-vs-Female |
1.060410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.70719999998048E-06 |
| Normal-vs-Age(41-60Yrs) |
6.77680000005232E-07 |
| Normal-vs-Age(61-80Yrs) |
1.79087999999661E-05 |
| Normal-vs-Age(81-100Yrs) |
2.965800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.360800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.475400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.477200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.847200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.717400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.743200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.98563000000096E-05 |
| Classical-VS-Follicular |
7.664400E-01 |
| Classical-VS-Other |
7.845600E-02 |
| Classical-VS-Normal |
3.64969999999687E-06 |
| Tall-VS-Follicular |
1.625910E-04 |
| Tall-VS-Other |
7.938600E-01 |
| Tall-VS-Normal |
6.67554900246614E-12 |
| Follicular-VS-Other |
1.542010E-01 |
| Follicular-VS-Normal |
1.00209999998047E-06 |
| Other-VS-Normal |
1.183910E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.32630000000556E-05 |
| Normal-vs-N1 |
2.19600004847109E-10 |
| N0-vs-N1 |
4.241600E-03 |
|
|
